Scott Leffler News Today

Cool Springs Medicare Advantage insurer makes changes during delisting threat

Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript February 27, 2024 Myriad Genetics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $0.02. Myriad Genetics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome […]

(RTTNews) - Physician enablement company, Clover Health Investments, Corp. (CLOV), Thursday said that its Chief Financial Officer Scott Leffler wi...

SALT LAKE CITY, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Clover Health Investments (NASDAQ:CLOV) stock is gaining on Thursday after the ...

SALT LAKE CITY, Dec. 21, 2023 -- Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced the appointment of Scott Leffler as Chief Financial Officer , effective...

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

GREENWICH, Conn., November 20, 2023--Greenbriar Equity Group, L.P. ("Greenbriar") today announced that funds managed by Greenbriar recently completed the growth recapitalization of VIVE Collision ("VIVE" or the "Company"), a leading multi-site collision repair operator, in partnership with the Company’s management and Garnett Station Partners, LLC ("Garnett Station"). Financial terms of the private transaction were not disclosed.

Operator: Ladies and gentlemen, good afternoon, and welcome to the Clover Health Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Operator: Ladies and gentlemen, good afternoon, and welcome to the Clover Health Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.